Carbidopa, Levodopa And Entacapone Tablet, Film Coated
Product Images NDC 62332-797

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa And Entacapone (NDC 62332-797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbilevoenta-carbidopa.jpg (Carbilevoenta Carbidopa)

Chemical structure of carbidopa monohydrate, showing its molecular configuration including phenol group, hydrazine moiety, and carboxylic acid with one water molecule (monohydrate).*

FDA Label Image

Carbilevoenta-levodopa.jpg (Carbilevoenta Levodopa)

Chemical structure diagram of carbidopa, levodopa and entacapone active ingredients showing molecular bonds and functional groups typical for these compounds.*

FDA Label Image

Carbilevoenta-entacapone.jpg (Carbilevoenta Entacapone)

Chemical structure diagram of the active ingredient carbidopa, levodopa and entacapone, showing the molecular arrangement and bonding typical of this compound class used in the product.*

FDA Label Image

Carbilevoent-12-5-50-200mg (Carbilevoent 12 5 50 200mg)

Label for Carbidopa, Levodopa and Entacapone Tablets showing strengths of 12.5 mg carbidopa, 50 mg levodopa, and 200 mg entacapone per film-coated tablet. The package contains 100 tablets, labeled for Rx only, manufactured by Alembic Pharmaceuticals Inc. The label also includes storage instructions, dosage warnings, and coding/lot information.*

FDA Label Image

Carbilevoent-18-75-75-200mg (Carbilevoent 18 75 75 200mg)

Label for Carbidopa, Levodopa and Entacapone Tablets, film coated, each containing Carbidopa 18.75 mg, Levodopa 75 mg, and Entacapone 200 mg. The label includes dosage instructions, storage conditions, manufacturer details (Alembic Pharmaceuticals Inc.), and a barcode. Package contains 100 tablets, Rx only.*

FDA Label Image

Carbilevoent-25-100-200mg (Carbilevoent 25 100 200mg)

Label for Carbidopa, Levodopa and Entacapone Tablets with strengths of 25 mg carbidopa, 100 mg levodopa, and 200 mg entacapone per film-coated tablet. The label includes storage instructions, dosage warnings, manufacturer Alembic Pharmaceuticals, Inc. and Alembic Pharmaceuticals Limited (India), and a 100 tablet count. Barcode and NDC 62332-797-31 are visible.*

FDA Label Image

Carbilevoent-31-25-125-200mg (Carbilevoent 31 25 125 200mg)

Label for Carbidopa, Levodopa and Entacapone Tablets by Alembic Pharmaceuticals Inc. Each film-coated tablet contains 31.25 mg Carbidopa USP, 125 mg Levodopa USP, and 200 mg Entacapone USP. The label includes storage instructions, dosage warnings, and packaging information. The product is supplied in a package of 100 tablets with NDC 62332-798-31.*

FDA Label Image

Carbilevoent-37-5-150-200 (Carbilevoent 37 5 150 200)

Label for Carbidopa, Levodopa and Entacapone Tablets containing 37.5 mg Carbidopa USP, 150 mg Levodopa USP, and 200 mg Entacapone USP per film-coated tablet. The label includes dosage instructions, storage conditions, manufacturer Alembic Pharmaceuticals Inc., and packaging information for 100 tablets.*

FDA Label Image

Carbilevoent-50-200-200mg (Carbilevoent 50 200 200mg)

Label for Carbidopa, Levodopa and Entacapone tablets, film coated, with strengths of 50 mg Carbidopa USP, 200 mg Levodopa USP, and 200 mg Entacapone USP per tablet. The label includes dosage instructions, storage conditions, manufacturer Alembic Pharmaceuticals Inc., and packaging of 100 tablets for oral use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.